Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.

Guest:

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

Related research: Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

Get new episodes of Hubwonk in your inbox!

Related Posts:

Origin of COVID-19: As Animal Source Evidence Eludes Scientists, Lab Leak Hypothesis Gains Purchase

This week on Hubwonk, host Joe Selvaggi talks with author and former New York Times science journalist Nicholas Wade about his recent article in the Bulletin of the Atomic Scientists on the possible origins of the SARS2 virus that caused the COVID-19 pandemic. In their conversation, they consider the possibility that, absent finding evidence of a natural jump from animals, the SAR2 virus may have come from a lab.

Pipelines Are Infrastructure: Colonial Incident Reveals Dark Side of Cyber Vulnerability

This week on Hubwonk, Host Joe Selvaggi talks with cyber security expert Dr. Brandon Valeriano about the Colonial Pipeline shutdown and our national exposure to cyberattack on vital infrastructure.

Fair Share Amendment: Weighing Costs & Benefits for Massachusetts’ Economy & Workers

Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Executive Director Jim Stergios about HB86, the so-called Fair Share Amendment, to tax Massachusetts household income above $1 million. They discuss its promises, its costs, and the effects of similar legislation in other states.

Talking Out Of School: Supreme Court Considers Campus Boundaries Within Social Media Universe

This week on Hubwonk, host Joe Selvaggi talks with constitutional scholar and CATO Institute Research Fellow Thomas Berry about the recently heard U.S. Supreme Court case, Mahanoy Area School District v. B.L., and its implications for free speech, school control, and the integration of social media into the rubric of first amendment protections.

Preparing For Disaster: Health Readiness Expert’s Performance Review

Hubwonk Host Joe Selvaggi talks with Emergency Preparedness expert Dr. Paul Biddinger about how experts plan for disasters, and what went right and wrong in this pandemic.

Post-Pandemic Possibilities: Writer Ramesh Ponnuru Offers Insight On What Comes Next

Host Joe Selvaggi talks with Bloomberg Opinion writer and National Review senior editor Ramesh Ponnuru about the national zeitgeist in a post-Covid, post-President Trump future.

Grading Education in a Pandemic: Survey Finds Teachers Pass, Administrations Fail & Students Incomplete

This week on Hubwonk, Joe Selvaggi discusses a recently released survey from Pioneer Institute and Emerson Polling, "Massachusetts Residents’ Perceptions of K-12 Education During the Covid-19 Pandemic," with Emerson's lead analyst, Isabel Holloway, and Pioneer Institute’s Charlie Chieppo.

Doctor Heal Thyself: Insider’s Prescription For Healthcare Reform

Host Joe Selvaggi talks with surgeon and New York Times bestselling author Dr. Marty Makary about the healthcare reform themes in The Price We Pay, the 2020 Business Book of the Year.  The discussion covers the value of price transparency, provider accountability, and performance information to drive better medical outcomes and improve doctor and patient satisfaction.

New Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

Pioneer Institute today released a new analysis, The QALY and Cancer Treatments: An Ill-Advised Match, that examines the alarming methodological and contextual shortcomings of the Quality Adjusted Life Years (QALY)-based methodology in evaluating new cancer therapies. The Pioneer Institute analysis reveals five specific problems with ICER’s evaluation of cancer treatments and demonstrates the urgent need to prohibit the use of the QALY amid trends in rapid cancer innovations and personalized medicine.

Travesty of Justice: Massachusetts Drug War Collapses on Lab Scandal

Joe Selvaggi talks with Pioneer Institute senior legal fellow Jim McKenna about Massachusetts’ drug prosecution cases resting on evidence produced by badly mismanaged drug testing labs, and the implications for potentially hundreds of thousands convicted on erroneous, tainted, or fabricated evidence.